Vaccines, Variants, and More: COVID-19 Year in Review

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.

Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.

From the Pharmacy of the Year winner announcement to a powerful Women in Pharmacy Workshop, here's what you missed on day 2 of ThoughtSpot.

Researchers analyzed the impact of the COVID-19 pandemic on outcomes for patients with pancreatic cancer living in England.

A PDUFA date for acoramidis has been set for November 29, 2024.